Paul Dorinsky
AstraZeneca (France)(FR)AstraZeneca (Netherlands)(NL)AstraZeneca (Spain)(ES)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Inhalation and Respiratory Drug Delivery, Respiratory and Cough-Related Research, Respiratory Support and Mechanisms
Most-Cited Works
- → The Salmeterol Multicenter Asthma Research Trial(2006)1,111 cited
- → Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD(2020)656 cited
- → Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial(2018)391 cited
- → Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study(2020)250 cited
- → Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma(2006)154 cited